AGILE THERAPEUTICS INC — key financial figures for fiscal year 2023 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2023)

$19.6M

Net Income/Loss (FY2023)

-$14.5M

Total Assets (FY2023)

$10.3M

Total Equity (FY2023)

-$16.3M

Cash Flows from Operating Activities (FY2023)

-$9.6M

Source: AGILE THERAPEUTICS INC 10-K filing (FY2023). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.